AMICOSANTE, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 11.739
AS - Asia 6.906
EU - Europa 6.278
SA - Sud America 873
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 16
Totale 25.939
Nazione #
US - Stati Uniti d'America 11.604
SG - Singapore 2.813
CN - Cina 1.491
IE - Irlanda 1.464
RU - Federazione Russa 1.198
TR - Turchia 889
DE - Germania 767
BR - Brasile 764
HK - Hong Kong 697
VN - Vietnam 521
GB - Regno Unito 519
IT - Italia 511
UA - Ucraina 438
SE - Svezia 419
FR - Francia 382
FI - Finlandia 290
IN - India 132
NL - Olanda 78
JP - Giappone 75
CA - Canada 62
BD - Bangladesh 49
MX - Messico 48
BE - Belgio 44
IQ - Iraq 37
ES - Italia 36
PL - Polonia 36
ZA - Sudafrica 36
AR - Argentina 35
ID - Indonesia 34
KR - Corea 22
EU - Europa 20
MA - Marocco 19
EC - Ecuador 18
UZ - Uzbekistan 18
CO - Colombia 16
LT - Lituania 16
PK - Pakistan 16
VE - Venezuela 16
CZ - Repubblica Ceca 15
RO - Romania 15
SA - Arabia Saudita 15
AU - Australia 12
CH - Svizzera 9
DZ - Algeria 9
IL - Israele 9
NP - Nepal 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
JO - Giordania 8
KE - Kenya 8
PY - Paraguay 8
BO - Bolivia 7
EG - Egitto 7
JM - Giamaica 7
KG - Kirghizistan 7
OM - Oman 7
PH - Filippine 7
IR - Iran 6
MD - Moldavia 6
MY - Malesia 6
AT - Austria 5
HU - Ungheria 5
TW - Taiwan 5
AL - Albania 4
CL - Cile 4
HN - Honduras 4
KZ - Kazakistan 4
PE - Perù 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
GA - Gabon 2
GR - Grecia 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HT - Haiti 1
KH - Cambogia 1
KI - Kiribati 1
Totale 25.923
Città #
Jacksonville 1.717
Singapore 1.624
Dublin 1.464
Chandler 1.463
Dallas 1.222
San Jose 906
Hong Kong 685
Ashburn 628
Santa Clara 562
Boardman 503
Izmir 489
The Dalles 389
Nanjing 313
Ann Arbor 284
Wilmington 248
Lawrence 228
Princeton 228
Moscow 217
New York 205
Seattle 186
Beijing 175
Ho Chi Minh City 163
Lauterbourg 159
Columbus 154
San Mateo 127
Hanoi 125
Milan 124
Nanchang 117
Los Angeles 102
Munich 83
Woodbridge 82
Council Bluffs 78
L'aquila 76
Mountain View 76
Bremen 74
Tokyo 72
São Paulo 70
Tianjin 65
Shenyang 63
Hebei 57
Düsseldorf 53
Verona 52
Kunming 47
Jiaxing 44
Jinan 44
Brussels 42
Turku 42
Dong Ket 41
Helsinki 40
Hefei 39
Des Moines 36
Frankfurt am Main 36
Orem 35
Dearborn 34
Warsaw 34
Denver 32
Shanghai 32
Fremont 31
Norwalk 31
Rio de Janeiro 31
Rome 31
Changsha 30
Chennai 27
Falls Church 27
Houston 27
Jakarta 27
Zhengzhou 27
Amsterdam 25
Atlanta 25
Belo Horizonte 25
Da Nang 24
Lanzhou 24
San Francisco 24
Brasília 22
Brooklyn 21
Chicago 21
Guangzhou 21
Johannesburg 21
Ningbo 21
Seoul 21
Montreal 20
L’Aquila 19
Stockholm 18
Falkenstein 17
Haiphong 17
London 17
Poplar 17
Phoenix 16
Tashkent 16
Toronto 16
Baghdad 15
Changchun 15
Mexico City 15
Manchester 14
Istanbul 13
Ankara 12
Nuremberg 12
Pelotas 12
Philadelphia 12
Dhaka 11
Totale 17.174
Nome #
OXA-23 Carbapenemase in Multidrug-Resistant Acinetobacter baumannii ST2 Type: First Identification in L'Aquila Hospital (Italy) 194
SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein 189
Ceftibuten stability to active-site serine and metallo-ß-lactamases 178
Ceftaroline in vitro activity against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci: a short report from Italy 171
In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and Delta E model methods 170
Broad spectrum β-lactamases of citrobacter diversus 170
CTX and its desacetyl derivative (des-CTX): Interaction with some representative β-lactamases and their related pattern of resistance to newer selected clinical isolates 169
Evaluations of the effects of extremely low-frequency electromagnetic fields on growth and antibiotic susceptibility of escherichia coli and pseudomonas aeruginosa 168
The 1.5-Å structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril 165
First Identification of β-Lactamases in Antibiotic-Resistant Escherichia coli, Citrobacter freundii, and Aeromonas spp. Isolated in Stream Macroinvertebrates in a Central Italian Region. 165
Cyclic and acyclic amine oxide alkyl derivatives as potential adjuvants in antimicrobial chemotherapy against methicillin-resistant staphylococcus aureus with an MDR profile 163
Inhibition of the transcriptional repressor LexA: Withstanding drug resistance by inhibiting the bacterial mechanisms of adaptation to antimicrobials 162
A class-A β-lactamase from Pseudomonas stutzeri that is highly active against monobactams and cefotaxime 160
Characterization of a β-lactamase produced in Mycobacterium fortuitum D316 160
Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species 158
Anti-apoptotic and anti-inflammatory activity of Gentiana lutea root extract 156
Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location 155
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease 155
In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates 154
β-lactamase of Mycobacterium fortuitum: Kinetics of production and relationship with resistance to β-lactam antibiotics 153
Interaction between antimicrobial peptides (AMPs) and their primary target, the biomembranes 152
Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex β-lactamase patterns including extended-spectrum enzymes 152
Cloning and nucleotide sequencing of the gene encoding the ß-lactamase from Citrobacter diversus 151
Replacement R164H and V240H by site-directed mutagenesis of TEM-149 ESBL: kinetic analysis of TEM-149H240 and TEM-149H164-H240 laboratory mutants 147
Beta-lactamase of Mycobacterium fortuitum: Introduction to the problem and first experimental data on purification and characterization 147
Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study 147
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates 147
Kinetic Study of the Effect of Histidines 240 and 164 on TEM-149 Enzyme Probed by β-Lactam Inhibitors. 146
Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1). 146
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 146
Emergence of blaKPC-3-Tn4401a in Klebsiella pneumoniae ST512 in the municipal wastewater treatment plant and in the university hospital of a town in central Italy. 145
Extremely low frequency (ELF) electromagnetic field (EMF) reduces quercetin-induced apoptosis in K562 cells: possible role of HSP-70 145
Amino acid replacement at position 228 induces fluctuation in the Ω-loop of KPC-3 and reduces the affinity against oxyimino cephalosporins: Kinetic and molecular dynamics studies 145
CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem 144
Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro 144
Kinetic studies on CphA mutants reveal the role of the P158-P172 loop in activity versus carbapenems 143
Use of chromatofocusing in purification of proteins 142
Interaction of neomycin with human erythrocytes 142
Interactions of biapenem with active-site serine and metallo-β-lactamases 142
Exploring the role of l10 loop in new delhi metallo-β-lactamase (Ndm-1): Kinetic and dynamic studies 142
Rapid characterization and partial purification of various animal amine oxidases 140
Influence of L-carnitine on CD95 cross-linking-induced apoptosis and ceramide generation in human cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases in vitro 140
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum β-lactamase genes cloned from a natural isolate and a high-level β-lactamase producer 140
Derivative spectroscopy as a nonperturbative tool to detect the state of liposome-entrapped sulbactam 140
Citrobacter diversus ULA27 produces two forms of a chromosomal β-lactamase 139
Interaction of carbapenems and β-lactamase inhibitors towards CTX-M-15 and CTX-M-15G238Cmutant 139
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales 139
Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey 138
Kinetic profile and molecular dynamic studies show that Y229W substitution in an NDM-1/L209F variant restores the hydrolytic activity of the enzyme toward penicillins, cephalosporins, and carbapenems 138
In vitro activity of cefodizime (HR-221) in combination with β-lactamase inhibitors 137
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten 137
Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa 137
BlaB-15, a new BlaB metallo-β-lactamase variant found in an Elizabethkingia miricola clinical isolate 136
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals 136
QnrB9 in association with TEM-116 extended-spectrum beta-lactamase in Citrobacter freundii isolated from sewage effluent: first report from Italy 135
Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain 134
β-Lactamases as major mechanism of resi stance in Gram-negative bacteria. 134
Identification of new natural CphA metallo-β-lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from municipal sewage in central Italy 134
Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase 133
Fractionation and characterization of two β-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing 133
P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency towards carbapenems. 133
Effects of extracts from lactic acid bacteria on tumor cell invasiveness in vitro 132
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum β-lactamase expressed in Escherichia coli 132
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary University hospital of Verona (Northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases. 132
Ceftazidime and aztreonam resistance in Providencia stuartii: Characterization of a natural TEM-derived extended-spectrum β-lactamase, TEM-60 131
Dynamical aspects of TEM-1 β-Lactamase probed by molecular dynamics 131
High specificity of cphA-encoded metallo-β-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to β-lactam resistance 130
Meropenem stability to β-lactamase hydrolysis and comparative in vitro activity against several β-lactamase-producing Gram-negative strains 129
Novel TEM-type extended-spectrum β-lactamase, TEM-134, in a Citrobacter koseri clinical isolate 129
In vitro Activity of Cefiderocol and Comparator Agents tested against Carbapenem-Resistant Acinetobacter baumannii (CRAb) from six Italian laboratories. 127
Curcumin inhibits the SOS response induced by levofloxacin in Escherichia coli 127
Kinetic study of laboratory mutants of NDM-1 metallo-β-lactamase and the importance of an isoleucine at position 35 127
Laboratory variants GESG170L, GESG170K, and GESG170H increase carbapenem hydrolysis and confer resistance to clavulanic acid 127
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators 127
Interaction between lichen secondary metabolites and antibiotics against clinical isolates methicillin-resistant staphylococcus aureus strains. 125
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital 125
Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities 125
A new metallo-beta-lactamase gene (blaIMP-22) harboured in class 1 integron from Pseudomonas fluorescens 125
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: Analysis of the quinolone resistance acquisition 125
Characterization of the chromosomal cephalosporinases produced by Acinetobacter Iwoffii and Acinetobacter baumannii clinical isolates 125
Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry 124
β-Lactamase induction antagonizes β-lactam susceptibilities in Citrobacter diversus and Enterobacter cloacae clinical isolates 124
Effect of V88L, M154L and A233V amino acid substitutions on NDM-1 metallo-β-lactamase: kinetic and dynamic studies. 123
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region 123
A Two Amino Acid Duplication, L167E168, in the X-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-Lactamase 122
Leucocianidine e collagenasi: inibizione dell’attività enzimatica “in vitro” 122
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase 122
On the kinetic interaction between ceftriaxone and some β-lactamases 121
Biochemical characterization of TEM-92 extended-spectrum β-lactamase, a protein differing from TEM-52 in the signal peptide 120
Use of the chromosomal class A β-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory β-lactam compounds 120
Photohemolysis of erythrocytes enriched with superoxide dismutase, catalase and glutathione peroxidase 119
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa 119
Decreased production of AmpC-type β-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains 119
Distribution of cphA or related carbapenemase-encoding genes and production of carbapenemase activity in members of the genus Aeromonas 119
Antibacterial activity of selected metabolites from Chilean lichen species against methicillin-resistant staphylococci 119
Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production 118
Comparative activity of piperacillin/tazobactam against clinical isolates of extended-spectrum β-lactamase-producing enterobacteriaceae 118
Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B ß-lactamase showing a broad substrate profile 117
Natural D240G Toho1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43 117
Proteolytic interconversion and N-terminal sequences of the Citrobacter diversus major β-lactamases 117
Totale 13.936
Categoria #
all - tutte 105.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021444 0 0 0 0 0 0 0 0 0 56 304 84
2021/20221.507 55 70 149 68 61 29 42 308 82 65 92 486
2022/20234.293 314 245 56 463 457 406 2 260 1.899 21 108 62
2023/2024867 143 69 77 91 72 213 21 69 8 25 25 54
2024/20254.856 89 69 415 256 743 483 670 466 876 178 422 189
2025/20267.950 441 890 969 958 902 725 1.376 299 686 704 0 0
Totale 26.753